千葉大学大学院医学研究院泌尿器科学・千葉大学医学部附属病院泌尿器科
English サイトマップ HOME
入局・研修をご希望の方 泌尿器科学教室について 患者様用当科診療案内
入局・研修をご希望の方
泌尿器科学教室について
患者様用当科診療案内
共通メニュー
HOME > 泌尿器科学教室について > 教室業績 > 2020年度教室業績
2020年度教室業績
英文原著
1 Kondoh Y, Azuma A, Inoue Y, Ogura T, Sakamoto S, Tsushima K, Johkoh T, Fujimoto K, Ichikado K, Matsuzawa Y, Saito T, Kishi K, Tomii K, Sakamoto N, Aoshima M, Araya J, Izumi S, Arita M, Abe M, Yamauchi H, Shindoh J, Suda T, Okamoto M, Ebina M, Yamada Y, Tohda Y, Kawamura T, Taguchi Y, Ishii H, Hashimoto N, Abe S, Taniguchi H, Tagawa J, Bessho K, Yamamori N, Homma S.  Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.   Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC. PMID: 31917621
2 Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Tamura K, Komiyama M, Goto T, Yokomizo A, Kohei N, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Iwamoto H, Mitsuzuka K, Morooka D, Shimazui T, Yamamoto Y, Ikeshiro S, Nakagomi H, Morita K, Tomida R, Mochizuki T, Inoue T, Kitamura H, Yamada S, Ito YM, Murai S, Nishiyama H, Shinohara N; Japanese Urological Oncology Group. Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma Cancer Sci. 2020 Jul;111(7):2460-2471. doi: 10.1111/cas.14449. Epub 2020 Jun 12. PMID: 32402135
3 Rii J, Sakamoto S, Yamada Y, Takeshita N, Yamamoto S, Sazuka T, Imamura Y, Nakamura K, Komiya A, Komaru A, Fukasawa S, Nakatsu H, Akakura K, Ichikawa T. Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients Prostate. 2020 Aug;80(11):850-858. doi: 10.1002/pros.24016. Epub 2020 Jun 5. PMID: 32501559
4 Namekawa T, Kitayama S, Ikeda K, Horie-Inoue K, Suzuki T, Okamoto K, Ichikawa T, Yano A, Kawakami S, Inoue S. HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroids. Cancer Lett. 2020 Oct 1;489:79-86. doi: 10.1016/j.canlet.2020.05.040. Epub 2020 Jun 13. PMID: 32544513
5 Wada M, Goto Y, Tanaka T, Okada R, Moriya S, Idichi T, Noda M, Sasaki K, Kita Y, Kurahara H, Maemura K, Natsugoe S, Seki N.   RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.   J Hum Genet. 2020 Nov;65(11):1019-1034. doi: 10.1038/s10038-020-0795-x. Epub 2020 Jul 4. PMID: 32623445
6 Sazuka T, Sakamoto S, Imamura Y, Nakamura K, Yamamoto S, Arai T, Takeuchi N, Komiya A, Teishima J, Ichikawa T. Relationship between post-void residual urine volume, preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma Int J Urol 2020 Nov;27(11):1024-1030.doi: 10.1111/iju.14352. Epub 2020 Sep 1. PMID: 32875619
7 Sakamoto S. Editorial Comment from Dr Sakamoto to Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens-like epithelium IJU Case Rep. 2020 Aug 1;3(5):174. doi: 10.1002/iju5.12177. eCollection 2020 Sep. PMID: 32914065
8 Sugiura M, Sato H, Okabe A, Fukuyo M, Mano Y, Shinohara KI, Rahmutulla B, Higuchi K, Maimaiti M, Kanesaka M, Imamura Y, Furihata T, Sakamoto S, Komiya A, Anzai N, Kanai Y, Luo J, Ichikawa T, Kaneda A. Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer TranslOncol.2020Oct20;14(1):100915.doi:10.1016/j.tranon.2020.100915. Online ahead of print. PMID: 33096335
9 Sugiura M, Sato H, Kanesaka M, Imamura Y, Sakamoto S, Ichikawa T, Kaneda A. Epigenetic modifications in prostate cancer Int J Urol. 2021 Feb;28(2):140-149. doi: 10.1111/iju.14406. Epub 2020 Oct 27. PMID: 33111429
10 Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Inoue T, Mizowaki T, Kamoto T, Kojima T, Kitamura H, Sugimoto M, Nishiyama H, Eto M; Japanese Urological Oncology Group (JUOG). Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients Cancer Sci. 2021 Apr;112(4):1524-1533. doi: 10.1111/cas.14722. Epub 2021 Feb 13. PMID: 33159829
11 Okada T, Taguchi K, Kato T, Sakamoto S, Ichikawa T, Yasui T. Efficacy of transurethral cystolithotripsy assisted by percutaneous evacuation and the benefit of genetic analysis in a pediatric cystinuria patient with a large bladder stone Urol Case Rep. 2020 Oct 28;34:101473. doi: 10.1016/j.eucr.2020.101473. eCollection 2021 Jan. PMID: 33194555
12 Yoneda K, Utsumi T, Wakai K, Oka R, Endo T, Yano M, Kamiya N, Hiruta N, Suzuki H. Preoperative Clinical Predictors of Lymphovascular Invasion of Bladder Tumors at Transurethral Resection Pathology Curr Urol. 2020 Oct;14(3):135-141. doi: 10.1159/000499247. Epub 2020 Oct 13. PMID: 33224006
13 Sato H, Imamura Y, Sakamoto S, Sugiura M, Arai T, Yamamoto S, Takeuchi N, Sazuka T, Nakamura K, Nagano H, Koide H, Tanaka T, Komiya A, Ichikawa T. Adrenalectomy in Japanese patients with subclinical Cushing syndrome: 1-mg dexamethasone suppression test to predict the surgical benefit Int J Urol. 2021 Mar;28(3):273-279. doi: 10.1111/iju.14445. Epub 2020 Nov 30. PMID: 33258172
14 Okada R, Goto Y, Yamada Y, Kato M, Asai S, Moriya S, Ichikawa T, Seki N. Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex ( miR-139-5p and miR-139-3p) in Renal Cell Carcinoma Biomedicines. 2020 Dec 12;8(12):599. doi: 10.3390/biomedicines8120599. PMID: 33322675
15 Sakamoto S Editorial Comment to Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study nt J Urol. 2021 Mar;28(3):288. doi: 10.1111/iju.14470. Epub 2020 Dec 16. PMID: 33327040
16 Sakamoto S Editorial Comment to Nomograms predicting the outcomes of endoscopic treatments for pediatric upper urinary tract calculi Int J Urol. 2021 Mar;28(3):301. doi: 10.1111/iju.14463. Epub 2020 Dec 24. PMID: 33368626
17 Nakai Y, Takeuchi A, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Morizane S, Kawasaki Y, Morooka D, Shimazui T, Yamamoto Y, Nakagomi H, Tomida R, Ito YM, Murai S, Kitamura H, Nishiyama H, Shinohara N; Japanese Urological Oncology Group. J Geriatr Oncol 2021 Jun;12(5):834-837. doi: 10.1016/j.jgo.2020.12.012. Epub 2020 Dec 31. PMID: 33388281
18 Yoneda K, Kamiya N, Utsumi T, Wakai K, Oka R, Endo T, Yano M, Hiruta N, Ichikawa T, Suzuki H. Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer-Comparison of Transurethral Resection and Radical Cystectomy Diagnostics (Basel). 2021 Feb 4;11(2):244. doi: 10.3390/diagnostics11020244. PMID: 33557407
19 Ando K, Sakamoto S, Saito S, Maimaiti M, Imamura Y, Sazuka T, Sato N, Komiya A, Anzai N, Ichikawa T Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel Cancers (Basel). 2021 Feb 12;13(4):773. doi: 10.3390/cancers13040773. PMID: 33673284
総説
1 Tamura T, Yoshioka Y, Sakamoto S, Ichikawa T, Ochiya T. Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets. Int J Mol Sci. 2020 Sep 12;21(18):6680.doi:10.3390/ijms21186680. PMID: 32932657
このページの先頭へ



一つ前のページへ戻る このページの先頭へ HOMEに戻る
copyright(C). Department of Urology. Graduate School of Medicine. Chiba University. All Rights Reserved.